Publications by authors named "Mario Lobigs"

Claim this Profile
P
Partial dysfunction of STAT1 profoundly reduces host resistance to flaviviral infection.
Maximilian Larena, Mario Lobigs

Virology· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ectromelia virus N1L is essential for virulence but not dissemination in a classical model of mousepox.
Carolina R Melo-Silva, David C Tscharke, Mario Lobigs, Aulikki Koskinen, Arno Müllbacher

Virus Res· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteolytic cleavage analysis at the Murray Valley encephalitis virus NS1-2A junction.
Siti Nor Khadijah Addis, Eva Lee, Jayaram Bettadapura, Mario Lobigs

Virol J· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutagenesis analysis of T380R mutation in the envelope protein of yellow fever virus.
Yan-Jang S Huang, John T Nuckols, Kate M Horne, Dana Vanlandingham, Mario Lobigs

Virol J· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Internal ribosome entry site-based attenuation of a flavivirus candidate vaccine and evaluation of the effect of beta interferon coexpression on vaccine properties.
Michael Frese, Eva Lee, Maximilian Larena, Pek Siew Lim, Sudha Rao, Mario Lobigs

J Virol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An inactivated cell culture Japanese encephalitis vaccine (JE-ADVAX) formulated with delta inulin adjuvant provides robust heterologous protection against West Nile encephalitis via cross-protective memory B cells and neutralizing antibody.
Nikolai Petrovsky, Maximilian Larena, Venkatraman Siddharthan, Natalie A Prow, Roy A Hall, Mario Lobigs

J Virol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytolytic effector pathways and IFN-γ help protect against Japanese encephalitis.
Maximilian Larena, Matthias Regner, Mario Lobigs

Eur J Immunol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
JE-ADVAX vaccine protection against Japanese encephalitis virus mediated by memory B cells in the absence of CD8(+) T cells and pre-exposure neutralizing antibody.
Maximilian Larena, Natalie A Prow, Roy A Hall, Nikolai Petrovsky, Mario Lobigs

J Virol· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The chemokine receptor CCR5, a therapeutic target for HIV/AIDS antagonists, is critical for recovery in a mouse model of Japanese encephalitis.
Maximilian Larena, Matthias Regner, Mario Lobigs

PLoS One· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of cross-protective vaccination against flaviviruses of the Japanese encephalitis serocomplex.
Mario Lobigs, Michael S Diamond

Expert Rev Vaccines· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ectromelia virus SPI-2 protein causes lethal mousepox by preventing NK cell responses.
Carolina R Melo-Silva, David C Tscharke, Mario Lobigs, Aulikki Koskinen, Yik Chun Wong

J Virol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determinants of attenuation in the envelope protein of the flavivirus Alfuy.
Natalie A Prow, Fiona J May, Daniel J Westlake, Robert J Hurrelbrink, Rebecca M Biron, Mario Lobigs

J Gen Virol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pivotal role of antibody and subsidiary contribution of CD8+ T cells to recovery from infection in a murine model of Japanese encephalitis.
Maximilian Larena, Matthias Regner, Eva Lee, Mario Lobigs

J Virol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An inactivated Vero cell-grown Japanese encephalitis vaccine formulated with Advax, a novel inulin-based adjuvant, induces protective neutralizing antibody against homologous and heterologous flaviviruses.
Mario Lobigs, Megan Pavy, Roy A Hall, Päivi Lobigs, Peter Cooper

J Gen Virol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of inactivation method on the cross-protective immunity induced by whole 'killed' influenza A viruses and commercial vaccine preparations.
Yoichi Furuya, Matthias Regner, Mario Lobigs, Aulikki Koskinen, Arno Müllbacher

J Gen Virol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytotoxic T cells are the predominant players providing cross-protective immunity induced by {gamma}-irradiated influenza A viruses.
Yoichi Furuya, Jennifer Chan, Matthias Regner, Mario Lobigs, Aulikki Koskinen

J Virol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A flavivirus signal peptide balances the catalytic activity of two proteases and thereby facilitates virus morphogenesis.
Mario Lobigs, Eva Lee, Mah Lee Ng, Megan Pavy, Päivi Lobigs

Virology· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Both E protein glycans adversely affect dengue virus infectivity but are beneficial for virion release.
Eva Lee, Sook Kwan Leang, Andrew Davidson, Mario Lobigs

J Virol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Caspase-dependent inhibition of mousepox replication by gzmB.
Julián Pardo, Eva María Gálvez, Aulikki Koskinen, Markus M Simon, Mario Lobigs

PLoS One· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intranasal flu vaccine protective against seasonal and H5N1 avian influenza infections.
Mohammed Alsharifi, Yoichi Furuya, Timothy R Bowden, Mario Lobigs, Aulikki Koskinen

PLoS One· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Live chimeric and inactivated Japanese encephalitis virus vaccines differ in their cross-protective values against Murray Valley encephalitis virus.
Mario Lobigs, Maximilian Larena, Mohammed Alsharifi, Eva Lee, Megan Pavy

J Virol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Restricted Semliki Forest virus replication in perforin and Fas-ligand double-deficient mice.
Mohammed Alsharifi, Mario Lobigs, Jayaram Bettadapura, Aulikki Koskinen, Arno Müllbacher

J Gen Virol· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
E protein domain III determinants of yellow fever virus 17D vaccine strain enhance binding to glycosaminoglycans, impede virus spread, and attenuate virulence.
Eva Lee, Mario Lobigs

J Virol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In situ reactions of monoclonal antibodies with a viable mutant of Murray Valley encephalitis virus reveal an absence of dimeric NS1 protein.
David C Clark, Mario Lobigs, Eva Lee, Megan J Howard, Kerri Clark

J Gen Virol· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD8(+) T cell-mediated immune responses in West Nile virus (Sarafend strain) encephalitis are independent of gamma interferon.
Yang Wang, Mario Lobigs, Eva Lee, Aulikki Koskinen, Arno Müllbacher

J Gen Virol· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis